News - PELOBiotech

PELONews: Animal Component-Free transition workflow

Animal Component-Free & Defined Culture of Human Primary Cells and Stem Cells FBS brings more than nutrients: lot variability, adventitious-agent risk, xenogenic contamination and regulatory paperwork. Learn how to move your human primary cells, MSCs and iPSCs to ACF or chemically defined culture—without losing growth, identity or function.

PELONews: Animal Component-Free & Defined Culture of Human Primary Cells and Stem Cells

Animal Component-Free & Defined Culture of Human Primary Cells and Stem Cells FBS brings more than nutrients: lot variability, adventitious-agent risk, xenogenic contamination and regulatory paperwork. Learn how to move your human primary cells, MSCs and iPSCs to ACF or chemically defined culture—without losing growth, identity or function.

PELONews: The EU wants to phase out animal testing

Non-animal does not always mean animal-free. As the EU moves toward reducing animal testing, the next challenge is building better, more reproducible in vitro systems with defined media, ACF solutions and human-relevant cell culture models.

New Products | Automated cell culture fluid management system

Discover the Signata CT-5® — a flexible, closed fluid management system designed to bring automation, consistency, and control to cell and gene therapy workflows.

New Products | CellSeal CryoCase and Cryogenic vials

From research to clinical manufacturing, CellSeal® CryoCase™ and CellSeal® Cryogenic Vials help protect valuable samples throughout the cryopreservation workflow.

New Products | Synvivo BBB on a chip and Lung brain axis on a chip

Advancing human health with organ on chip models

New Products | Slingshot Biosciences: synthetic flow cytometry controls ScatterBridgeTM

Slingshot Biosciences produces a portfolio of synthetic cell mimics, polymer-based particles engineered to recapitulate the biophysical, optical, and biochemical properties of primary cells addressing well-documented limitations of biologically derived controls in flow cytometry, cell therapy QA/QC, and assay development.

New Products | Slingshot Biosciences: synthetic flow cytometry controls ViaComp®

Slingshot Biosciences produces a portfolio of synthetic cell mimics, polymer-based particles engineered to recapitulate the biophysical, optical, and biochemical properties of primary cells addressing well-documented limitations of biologically derived controls in flow cytometry, cell therapy QA/QC, and assay development.

New Products | Slingshot Biosciences: synthetic flow cytometry controls TrueCytesTM®

Slingshot Biosciences produces a portfolio of synthetic cell mimics, polymer-based particles engineered to recapitulate the biophysical, optical, and biochemical properties of primary cells addressing well-documented limitations of biologically derived controls in flow cytometry, cell therapy QA/QC, and assay development.

PELONews: Stem cells

In this months newsletter we delve into how stem cells such as mesenchymal stromal cells (MSCs) and iPSC cells play a role in patient centric translatable research for drug development.